ISCTglobal Profile Banner
ISCT Profile
ISCT

@ISCTglobal

Followers
5K
Following
3K
Media
1K
Statuses
3K

Driving the translation of cell & gene therapies for the benefit of patients worldwide. Also on BlueSky: https://t.co/UpnK6ZETW6

Head Office: Vancouver, Canada
Joined January 2015
Don't wanna be here? Send us removal request.
@ISCTglobal
ISCT
1 day
In under two weeks, the 2025 cohort dives into the Hands-On Lab Bootcamp for Cell Therapy Biomanufacturing at Georgia Tech, gaining fundamental lab skills in CGT production. Couldn't make it this year? Drop your email and we'll help you plan for 2026:
0
0
3
@ISCTglobal
ISCT
2 days
Meet Dr. Chaiyong Koaykul, Ph.D., ISCT 2025 Trailblazer Award recipient for Emerging Markets. Dr. Koaykul joins Telegraft contributing editor, Ashley Angell Krull, Ph.D., sharing insights into the opportunities and challenges in Asia for #celltherapy.
Tweet media one
1
0
0
@ISCTglobal
ISCT
2 days
ISCT welcomes new industry members from diverse regions and specialties, joining 60+ existing Industry members to tackle challenges and drive growth. Ready to connect and build momentum for 2026? Enhance your org's influence with our 18-month membership:
Tweet media one
0
0
0
@ISCTglobal
ISCT
3 days
Class is almost in session! Next month, learners will explore essential lab techniques and best practices for cell bioprocessing in GMP labs. While our hands-on bootcamp is full, access on-demand modules and live-virtual discussions:
Tweet media one
Tweet media two
1
1
0
@ISCTglobal
ISCT
7 days
Our sold-out ISCT ANZ 2025 Regional Meeting was a great success, inspiring attendees about the future of cell and gene therapy. Thanks to everyone involved, and if you couldn't attend - we hope to welcome you in 2026! Full recap in September 2025's Telegraft. #ISCTANZ2025
Tweet media one
2
0
4
@ISCTglobal
ISCT
8 days
Engage in our discussion about the future of affordable CAR-T cell therapy in India and its impact on making treatment more accessible. Explore India's progress in CAR-T research and clinical advancements, highlighted by a groundbreaking approval. 🔗
Tweet media one
0
5
8
@ISCTglobal
ISCT
9 days
SCGT 2025 highlighted Asia's thriving Cell and Gene Therapy ecosystem, featuring world-class keynotes, local innovations, and a SCSS-ISCT collaboration. Discover more on Telegraft as we build excitement for the 2026 ISCT Asia Meeting in Singapore!
Tweet media one
0
0
2
@ISCTglobal
ISCT
10 days
ISCT leaders at ISCT ANZ 2025 in Sydney, featuring Regional VP Emily Blyth, President-Elect Daniel J. Weiss, and Regional VP-Elect Siok Tey. Since 2018, ISCT ANZ has linked top clinicians, researchers, and industry experts. Share your highlights and photos with #ISCTANZ2025.
Tweet media one
0
0
2
@ISCTglobal
ISCT
11 days
Insta-Your-Cells photo challenge is back! Capture your best images to win complimentary registration to ISCT 2026 Dublin Scientific Annual Meeting, and have your work featured on the front cover of Cytotherapy, ISCT's official journal!. Submit now:
Tweet media one
0
0
1
@ISCTglobal
ISCT
14 days
August 2025 Issue of Telegraft is here! Catch updates on feature articles, a new Cytotherapy podcast and the latest regulatory insights from Europe, South & Central America, and North America. Plus, discover cell therapy developments from industry partners
Tweet media one
0
1
2
@ISCTglobal
ISCT
14 days
Discover how professionals benefit from our Principles & Applications of Cell Therapy Biomanufacturing, Characterization, and Regulatory course, and how your team can too. Learn more and register:
Tweet media one
0
0
2
@ISCTglobal
ISCT
21 days
ISCT ANZ 2025 Regional Meeting is SOLD OUT! Shoutout to ISCT Leadership and the ANZ Regional Committee for their efforts. Stay tuned for updates and recaps. Join us at ISCT 2026 in Dublin and ISCT Asia 2026 in Singapore:
Tweet media one
0
0
5
@ISCTglobal
ISCT
23 days
Explore CGT regulation at Telegraft Hub! Learn about MHRA's 2025 Human Medicines Modular Manufacture and Point of Care regulations: and gain insights from the FDA CGT Roundtable on modernizing cell and gene therapy regulations:
Tweet media one
Tweet media two
0
1
3
@ISCTglobal
ISCT
24 days
Just 1 month to go! Join the Hands-On Laboratory Bootcamp in Cell Therapy Biomanufacturing (registration deadline: Aug 8, 2025). Spaces are filling fast, don't forget to register today: . Check out these highlights from last year’s program.
Tweet media one
Tweet media two
Tweet media three
0
1
4
@ISCTglobal
ISCT
28 days
SCGT 2025 wrapped up last week, featuring key ISCT members! . Look forward to ISCT Asia 2026, where top researchers, healthcare professionals and industry experts gather to support the advancement of cell and gene therapy. Subscribe for updates:
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
1
@ISCTglobal
ISCT
28 days
The ISCT ESP Committee is seeking new members! Apply by August 19, 2025, with your CV, a statement of interest, and your top three choices for Working Groups. Learn more and apply: Not yet an ISCT member? Become one today:
Tweet media one
0
0
1
@ISCTglobal
ISCT
29 days
The ISCT Institute of Training & Development offers resources for learner preparation, engagement, and reference. A letter of support is now available for prospective learners, and a social media kit is provided for current learners. Check it out now!
Tweet media one
0
0
0
@ISCTglobal
ISCT
3 months
RT @BLLPHD: 🚨NEW REVIEW- The Next Innovations in Chimeric Antigen Receptor T Cell Immunotherapies for Cancer.-Armored CAR T cells.-Genetic….
0
25
0
@ISCTglobal
ISCT
6 months
Last day for our course on Hands-on Methods and Analytical Processes for Cell and Gene Therapy Bioprocessing! It was great to be in San Diego, with our partners from Patheon Pharma Services:. Looking to join our next course? Join us at Georgia Tech .
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
0
2
@ISCTglobal
ISCT
7 months
Announcing our inaugural Keynote Speaker for ISCT 2025!. Join us on the evening of Friday, May 9th, as Dr. Fred Applebaum discusses the status of our sector and projects into its future. #ISCT2025. Learn more at
Tweet media one
0
3
7